ArticleJournal of clinical immunology2017

Allogeneic Reduced-Intensity Hematopoietic Stem Cell Transplantation for Chronic Granulomatous Disease: a Single-Center Prospective Trial.

Mark Parta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.